Mechanism of Action of St. John's Wort (Hypericum perforatum)
St. John's wort primarily acts as a P-glycoprotein (P-gp) inducer and inhibits the reuptake of several neurotransmitters including serotonin, dopamine, and norepinephrine, with hyperforin emerging as the main constituent responsible for its antidepressant effects.
Primary Mechanisms of Action
Neurotransmitter Effects
- Inhibition of synaptosomal uptake: St. John's wort inhibits the reuptake of serotonin, dopamine, and norepinephrine with approximately equal affinity 1
- Hyperforin: This phloroglucinol derivative has emerged as the primary constituent responsible for antidepressant activity, rather than hypericin as originally thought 2
- Receptor interactions: Shows significant affinity for adenosine, GABA(A), GABA(B), and glutamate receptors in vitro 1
Enzyme Induction Effects
- P-glycoprotein induction: Acts as a strong P-gp inducer, which can significantly decrease the maximum concentration (Cmax) and area under the curve (AUC) of drugs that are P-gp substrates 3
- CYP450 induction: Induces cytochrome P450 enzymes, particularly CYP3A4, CYP2C9, and CYP2C19, leading to enhanced clearance of many medications 3
Neurobiological Changes
- Receptor regulation: In vivo studies show St. John's wort leads to downregulation of beta-adrenergic receptors and upregulation of serotonin 5-HT(2) receptors in the rat frontal cortex 1
- Neurotransmitter concentrations: Causes changes in neurotransmitter concentrations in brain areas implicated in depression 1
- Neuroendocrine effects: Recent studies suggest involvement in the regulation of genes that control hypothalamic-pituitary-adrenal axis function 1
Active Constituents
- Naphthodianthrones: Including hypericin, which contributes to pharmacological activities and is responsible for photosensitive reactions 2
- Phloroglucinols: Particularly hyperforin, the main contributor to antidepressant effects 1
- Flavonoids: Several flavonoid constituents also contribute to the overall antidepressant effect 1
- Other compounds: Biflavones, proanthocyanidines, and xanthones have been identified in the crude material 1
Clinical Implications
Drug Interactions
- Decreased drug efficacy: Due to its P-gp induction properties, St. John's wort can significantly decrease the effectiveness of many medications 3
- Specific interactions: Known to interact with:
- Anticoagulants (warfarin)
- Immunosuppressants (cyclosporine)
- Antiretrovirals (HIV protease inhibitors)
- Antiepileptics
- Oral contraceptives
- Selective serotonin reuptake inhibitors 2
Perioperative Considerations
- Discontinuation timing: Should be held for at least 2 weeks before surgery due to its long half-life constituents (such as hypericin) and enzyme induction effects 3
- Serotonin syndrome risk: Can increase risk when combined with other serotonergic medications like meperidine or tramadol 3
Therapeutic Efficacy
- Comparable to SSRIs: Meta-analyses show St. John's wort has comparable efficacy to standard SSRIs for mild to moderate depression 4
- Better tolerability: Demonstrates significantly lower discontinuation/dropout rates compared to standard SSRIs 4
- Limited evidence for severe depression: Unclear if beneficial for patients with severe depression or high suicidality 4
Important Caveats
- Standardization issues: As an herbal product, potency and composition can vary between preparations
- Delayed onset: Like conventional antidepressants, full effects may take several weeks to manifest
- Self-medication risks: Patients may not disclose use to healthcare providers, leading to potential drug interactions
- Limited long-term data: Most studies range from 4-12 weeks, with limited evidence on long-term safety and efficacy 4
St. John's wort's complex mechanism of action involving multiple neurotransmitter systems and enzyme induction pathways explains both its therapeutic effects and potential for significant drug interactions.